Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001062993-24-005761

President sold 39,070 shares at an average $3.47 ($135,764)

  • President acquired 175,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

RUBINSTEIN JULIE · President

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-03-04 Grant or award : show line 1 in the form +175,000 511,824 D
2024-03-05 Sale : show line 2 in the form −25,580 $3.43 $87,739 486,244 D
2024-03-05 Sale : show line 3 in the form −13,490 $3.56 $48,024 472,754 D
Open-market sales · 39,070 sh · avg $3.47 · $135,764
Loading xslF345X05/form4.xml…